Veos Pharmaceuticals Unveils ThymoTropin to Support Muscle Health and Preservation During Weight Loss and Aging Journeys

Introducing ThymoTropin: A Groundbreaking OTC Solution for Muscle Health by Veos Pharmaceuticals MADRID, Spain, 21st Jan 2025, – Veos Pharmaceuticals, a leading innovator with a portfolio of nearly 40 products …

Veos Pharmaceuticals Unveils ThymoTropin to Support Muscle Health and Preservation During Weight Loss and Aging Journeys Read More

China Medical System(00867)Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Rα Monoclonal Antibody MG-K10

SHENZHEN, CHINA – China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on 24 January 2025, the Group through …

China Medical System(00867)Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Rα Monoclonal Antibody MG-K10 Read More